<!DOCTYPE html><html lang="en"><head><meta name="generator" content="Scully 0.0.0">
  <meta charset="utf-8">
  <title>NgxGardSkully 123</title>
  <base href="/">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <link rel="icon" type="image/x-icon" href="favicon.ico">
<link rel="stylesheet" href="styles.4cdd1989b7928c8b693d.css"><style>body,html{overflow-x:hidden}@media (max-width:991.98px){.offcanvas-collapse{position:fixed;top:56px;bottom:0;left:100%;width:100%;padding-right:1rem;padding-left:1rem;overflow-y:auto;visibility:hidden;background-color:#343a40;transition:transform .3s ease-in-out,visibility .3s ease-in-out}.offcanvas-collapse.open{visibility:visible;transform:translateX(-100%)}}.nav-scroller{position:relative;z-index:2;height:2.75rem;overflow-y:hidden}.nav-scroller .nav{display:flex;flex-wrap:nowrap;padding-bottom:1rem;margin-top:-1px;overflow-x:auto;color:hsla(0,0%,100%,.75);text-align:center;white-space:nowrap;-webkit-overflow-scrolling:touch}.nav-underline .nav-link{padding-top:.75rem;padding-bottom:.75rem;font-size:.875rem;color:#6c757d}.nav-underline .nav-link:hover{color:#007bff}.nav-underline .active{font-weight:500;color:#343a40}.text-white-50{color:hsla(0,0%,100%,.5)}.bg-purple{background-color:#6f42c1}.lh-100{line-height:1}.lh-125{line-height:1.25}.lh-150{line-height:1.5}.splitter{margin-left:20px;margin-right:20px;display:inline-block;font-size:20px;transform:scaleX(.3)}.banner{background-color:#1b5b76;height:116px;background-image:url(https://rarediseases.info.nih.gov/content/images/banner-touch-diseases.jpg);background-repeat:no-repeat;background-position:100%}.search-ct{top:40px;left:30px}.footer{background:#d3d3d3;height:230px}.footer-links{padding-top:20px}.footer-text{margin-top:30px;text-align:center}.input-group-text{cursor:pointer}</style><style></style><script>window['ScullyIO']='generated';</script><script>window.ScullyIOAngularDisabled = true;</script></head>
<body scully-version="0.0.0">
  <app-root ng-version="10.0.14"><nav class="navbar navbar-dark sticky-top bg-dark flex-md-nowrap p-0 shadow"><span class="shrink-width"><ul class="navbar-nav px-3 list-inline"><li class="nav-item text-nowrap list-inline-item"><span href="#" class="nav-link">U.S. Department of Health &amp; Human Services <span class="splitter"> &gt; </span> National Institutes of Health <span class="splitter"> &gt; </span> NCATS</span></li></ul></span></nav><div class="shrink-width"><div class="nav-scroller bg-white shadow-sm justify-content-center"><nav class="nav nav-underline"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases">Diseases</a><a routerlink="/help" routerlinkactive="active" class="nav-link" href="/help">Guides</a><a routerlink="/about" routerlinkactive="active" class="nav-link" href="/about">News</a><a routerlink="/glossary" routerlinkactive="active" class="nav-link" href="/glossary">About GARD</a><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases">En Espanõl</a></nav></div><form novalidate="" class="ng-untouched ng-pristine ng-valid"><div class="banner"><div class="col-md-6 search-ct"><div class="input-group mb-3"><input formcontrolname="search" type="text" placeholder="Search for Diseases, Organizations, News and More..." aria-label="Search for Diseases, Organizations, News and More..." aria-describedby="basic-addon2" class="form-control ng-untouched ng-pristine ng-valid"><span class="input-group-text">GO</span></div></div></div></form><div class="container-fluid"><router-outlet></router-outlet><app-disease-details><div class="row"><div class="col-md-3"><nav><div class="sidebar-sticky pt-3"><ul class="nav flex-column"><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> Browse A-Z </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> Find Diseases By Category </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> List of FDA Orphan Drugs </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> GARD Information Navigator </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> FAQs About Rare Diseases </a></li></ul></div></nav></div><main role="main" class="col-md-9"><div class="d-flex justify-content-between flex-wrap flex-md-nowrap align-items-center pt-3 pb-2 mb-3 border-bottom"><h1 class="h2">Disease # 13406 - Limbic encephalitis with LGI1 antibodies</h1></div><div><p><b>Other Names: </b>Limbic encephalitis with leucine-rich glioma-inactivated 1 antibodies</p><p><b>Categories: </b><span> Nervous System Diseases</span><!----></p><p><b>This disease is grouped under: </b>Limbic encephalitis</p><p><b>Summary: </b><span><strong>Limbic encephalitis with LGI1 antibodies</strong> is a relatively new disease characterized by progressive memory loss, confusion, sleep disturbances, and problems with behaviors and spatial orientation. Seizures are common and frequently precede other symptoms. About half of people with this diagnosis exhibit a specific type of seizure called faciobrachial dystonic seizures, which resemble brief jerks of the face arm.[14204][14206][14207][14208][14209][14210] <a href="https://medlineplus.gov/ency/article/000394.htm" target="_blank">Hyponatremia</a>&nbsp;(low levels of sodium in the blood) may also be present.[14204][14207][14210] The disease occurs when antibodies mistakenly attack LGI1 (leucine-rich glioma inactivated 1), a protein found in the brain that binds together two epilepsy-related proteins called ADAM22 and ADAM23.[14204][14209][14210] Some people with limbic encephalitis with LGI1 antibodies (5 to 10%) also have a cancer diagnosis (most commonly <a href="https://www.cancer.net/cancer-types/thymoma?sectionTitle=Overview" target="_blank">thymoma</a> and lung cancer), but most do not.[14204][14210]&nbsp;<br>
<br>
The disease is diagnosed through testing of blood or spinal fluid for LGI1 antibodies.[14204][14207][14209] If treatment is started when seizures are first noticed, limbic encephalitis may be prevented.[14204][14206] Treatment is intravenous or oral corticosteroids, <a href="https://www.webmd.com/a-to-z-guides/immunoglobulin-therapy#1" target="_blank">intravenous immunoglobulin</a> (IVIG), <a href="https://www.hopkinsmedicine.org/transplant/programs/kidney/incompatible/plasmapheresis.html" target="_blank">plasmapheresis</a> (a process where antibodies are removed from the blood), or a combination of these.[14204][14207][14209][14210] Long-term outcome is mostly favorable, although some people are left with some degree of residual impairment. Relapse occurs in up to one third of patients.[14204][14209][14211][14212]</span></p><div><b>Organizations: </b><ul><li><span><a href="org.url">Encephalitis Society</a></span><br><span>32 Castlegate</span><br><span> , </span><br><!----><!----></li><!----></ul></div><div><b>Learn More</b><ul><li><span><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Anti-LGI1+Limbic+Encephalitis" target="_blank">PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Limbic encephalitis with LGI1 antibodies. Click on the link to view a sample search on this topic.</span></li><li><span><a href="http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=163908" target="_blank">Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br>
</span></li><li><span>The <a href="https://www.encephalitis.info/lgi1caspr2-antibody-encephalitis" target="_blank">Encephalitis Society</a> offers a factsheet on&nbsp;Limbic encephalitis with LGI1 antibodies</span></li><li><span>van Sonderen A, Schreurs MW, Wirtz PW, Sillevis Mitt PA, Titulaer MJ.&nbsp;<a href="http://www.sciencedirect.com/science/article/pii/S156899721630163X?via%3Dihub" target="_blank">From VGKC to LGI1 and Caspr2 encephalitis: The evolution of a disease entity over time</a>. <em>Autoimmun Rev</em>. 2016 Oct; 15(10):970-4.</span></li><li><span>Ariño H, Armangué T, Petit-Pedrol M, Sabater L, Martinez-Hernandez E, Hara M, Lancaster E, Saiz A, Dalmau J, Graus F.&nbsp;<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999321/" target="_blank">Anti-LGI1–associated cognitive impairment:  Presentation and long-term outcome</a>. <em>Neurology</em>. 2016 Aug 23; 87(8):759-65.</span></li><li><span>Varley J, Taylor J, Irani SR.&nbsp;<a href="https://www.sciencedirect.com/science/article/pii/S002839081730196X" target="_blank">Autoantibody-mediated diseases of the CNS: Structure, dysfunction and therapy</a>.&nbsp;<em>Neuropharmacology</em>. 2017:1-12.</span></li><li><span>Aurangzeb S, Symmonds M, Knight RK, Kennett R, Wehner T, Irani SR.&nbsp;<a href="https://www.sciencedirect.com/science/article/pii/S1059131117302893" target="_blank">LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures</a>. <em>Seizure</em>. August 2017; 50:14-17.</span></li><!----></ul></div></div></main><!----></div></app-disease-details><!----></div></div><div class="footer"><div class="shrink-width"><div class="footer-links row align-items-center"><div class="col"><a href="/" target="_self">GARD Home</a></div><div class="col"><a href="http://ncats.nih.gov/" target="_blank">NCATS Home</a></div><div class="col"><a href="/sitemap" target="_self">Site Map</a></div><div class="col"><a href="/glossary" target="_self">Browse Glossary A-Z</a></div><div class="col"><a href="/pages/36/privacy-notice" target="_self">Privacy Notice</a></div><div class="col"><a href="/pages/37/disclaimer" target="_self">Disclaimer</a></div><div class="col"><a href="/pages/38/accessibility" target="_self">Accessibility</a></div><div class="col"><a href="/pages/39/foia" target="_self">FOIA </a></div><div class="col"><a href="http://oig.hhs.gov/" target="_blank">OIG</a></div></div><div class="footer-text"><p> If you have problems viewing PDF files, download the latest version of <a target="_blank" href="https://get.adobe.com/reader/" class="footer-links">Adobe Reader</a></p><p> For <a f="http://edi.nih.gov/consulting/language-access-program/about" target="_blank" title="Read the plan" class="ext">language access</a> assistance, contact the <a href="mailto: info@ncats.nih.gov" title="E - mail Public Information Officer" class="footer-links">NCATS Public Information Officer</a></p><p> Genetic and Rare Diseases Information Center (GARD) - PO Box 8126, Gaithersburg, MD 20898-8126 - Toll-free: 1-888-205-2311 </p></div></div></div></app-root>

<script src="js/custom.js"></script>

</body></html>